{"Title": ["Zacks.com featured highlights include: Ralph Lauren, Estee Lauder, GMS, CytRx and T2 Biosystems", "Bet on Rising P/E Investing With These 5 Top-Ranked Stocks", "5 Biotech Stocks Under $10 Worthy of Investors' Attention", "Health Care Sector Update for 07/28/2017: ENTA, ABBV, CYTR, ATNM", "Health Care Sector Update for 07/28/2017: LMAT,CYTR,ATNM", "Health Care Sector Update for 06/08/2017: JNJ, PFE, ABT, MRK, AMGN, CYTR, TGTX, QGEN", "Wall Street Set to Open in Red Territory, Data in Focus", "US Futures Slip Ahead of Economic Data", "Zacks.com featured highlights include: Ralph Lauren, Estee Lauder, GMS, CytRx and T2 Biosystems", "Bet on Rising P/E Investing With These 5 Top-Ranked Stocks", "5 Biotech Stocks Under $10 Worthy of Investors' Attention", "CytRx (CYTR) Is in Oversold Territory: What's Next?", "What Awaits ACUR & Other Drug Stocks this Earnings Season?", "Weight Watchers (WTW) Q2 Earnings: A Surprise in Store?", "Should You Buy CytRx (CYTR) Ahead of Earnings?", "Thursday Sector Leaders: Trucking, Drugs", "CytRx Gets Clarity from FDA for Aldoxorubicin NDA, Shares Up", "Is the Options Market Predicting a Spike in CytRx Corp (CYTR) Stock?", "Health Care Sector Update for 12/13/2016: CYTR,AKAO,PRTO", "CytRx (CYTR) Is in Oversold Territory: What's Next?", "What Awaits ACUR & Other Drug Stocks this Earnings Season?", "Weight Watchers (WTW) Q2 Earnings: A Surprise in Store?", "Should You Buy CytRx (CYTR) Ahead of Earnings?", "Thursday Sector Leaders: Trucking, Drugs", "CytRx Gets Clarity from FDA for Aldoxorubicin NDA, Shares Up", "Is the Options Market Predicting a Spike in CytRx Corp (CYTR) Stock?", "Health Care Sector Update for 12/13/2016: CYTR,AKAO,PRTO", "CytRx (CYTR) Is in Oversold Territory: What's Next?", "What Awaits ACUR & Other Drug Stocks this Earnings Season?", "Weight Watchers (WTW) Q2 Earnings: A Surprise in Store?", "Should You Buy CytRx (CYTR) Ahead of Earnings?", "Thursday Sector Leaders: Trucking, Drugs", "HCA Holdings (HCA) Q2 Earnings: Uncertainty in the Cards?", "Varian (VAR): What's in Store for the Stock in Q3 Earnings?", "Can CryoLife (CRY) Earnings Spring a Surprise in Q2?", "C.R. Bard (BCR) Well Poised to Beat Q2 Earnings Estimates?", "Sarepta (SRPT) Posts Y/Y Wider Q2 Loss, Eteplirsen in Focus", "CytRx (CYTR) Is in Oversold Territory: What's Next?", "Merck KGaA's Multiple Sclerosis Drug under Review in EU", "Can Ecolab (ECL) Spring an Earnings Surprise in Q2?", "Adeptus Health (ADPT) Q2 Earnings: Will it Beat Estimates?", "athenahealth (ATHN) Q2 Earnings: What's in the Cards?", "Mid-Day Market Update: U.S. Stocks Turn Lower; Iteris Shares Climb Following Q1 Sales Outlook", "Mid-Morning Market Update: Markets Open Higher; Wells Fargo Earnings Meet Estimates", "Intuitive Surgical (ISRG) Q2 Earnings: What's in Store?", "Bio-Techne (TECH) Set to Acquire Space Import-Export", "Notable Wednesday Option Activity: MNKD, CYTR, BMY", "Mid-Day Market Update: Crude Oil Up 3%; Seagate Shares Surge On Strong Revenue Guidance", "Noteworthy Tuesday Option Activity: CYTR, BIIB, Z", "Notable Tuesday Option Activity: CYTR, GILD, CKEC", "CytRx Corp (CYTR) in Focus: Stock Rises 10.2% in Session", "Mid-Day Market Update: Ruckus Wireless Surges On Acquisition News; Smith & Wesson Shares Slide", "Monday Sector Leaders: Drugs, Biotechnology Stocks", "Mid-Day Market Update: Affymetrix Stock Drops; Valeant Shares Spike Higher", "Mid-Morning Market Update: Markets Edge Lower; Sherwin-Williams To Buy Valspar For $113/Share", "New Strong Buy Stocks for July 5th", "New Strong Buy Stocks for January 14th", "Surging Earnings Estimates Signal Good News for CytRx (CYTR)", "Noteworthy Tuesday Option Activity: CYTR, GNC, TROV", "Mid-Morning Market Update: Markets Open Higher; Lennar Tops Q3 Views", "Will CytRx (CYTR) Continue to Surge Higher?", "Mid-Day Market Update: Dow Dips Over 1%; Harley-Davidson Shares Rise On Earnings Beat", "Health Care Sector Update for 07/21/2015: NVS, CYTR", "Will CytRx (CYTR) Continue to Surge Higher?", "Why Shares in CytRx Corporation Are Surging Higher", "CytRx Corporation (CYTR) Jumps: Stock Rises 11.3% - Tale of the Tape", "Why CytRx Corporation Shares Are Soaring Today", "CytRx Candidate Encourages in Soft Tissue Sarcoma Study - Analyst Blog", "Advaxis: Heavily Promoted And Misleading Investors", "CytRx Relieved as FDA Lifts Partial Hold on Oncology Drug - Analyst Blog", "CytRx Jumps on Positive Results from Brain Cancer Study - Analyst Blog", "Should You Get Rid of CytRx Corporation (CYTR) Now? - Tale of the Tape", "Health Care Sector Update for 01/06/2015: CYTR,TNXP,MSTX", "Mid-Morning Market Update: Markets Gain; Pacific Ethanol Reports Merger Deal With Aventine Renewable Energy", "CytRx Falls on Written FDA Notice for Aldoxorubicin Study - Analyst Blog", "Health Care Sector Update for 11/18/2014: NBS, CYTR", "5 Red-Hot Biotech Stocks to Buy", "Sector Update: Healthcare Stocks Mixed; CytRx Ahead 6% After Launching New Drug-Discovery Lab", "Sector Update: Health Care", "Mid-Morning Market Update: Markets Open Higher; Commercial Metals Posts Upbeat Earnings", "Three Lessons From The Galena Scandal", "Healthcare Stocks Little Changed; CytRx Climbs More Than 7% after Cancer Drug Extends Progression-Free Survival", "Sector Update: Healthcare", "Mid-Day Market Update: Weight Watchers Shares Surge On Upbeat Results; JDS Uniphase Tumbles", "Mid-Afternoon Market Update: Markets Turn Back As Meritor Hangs Onto Its Gains", "Behind The Scenes With Proactive, Inovio And Unilife", "Behind The Scenes With Dream Team, CytRx And Galena", "3 Lessons From The Galena Scandal", "Healthcare Stocks Falling Hard This Afternoon; CytRx Hits 15-Month High After Prospective Cancer Drug Tests Well", "Sector Update: Healthcare", "Stocks: Insiders Sell at Google and LinkedIn", "Shares Fall as CytRx Prices Stock Offer - Analyst Blog", "Healthcare Stocks Inching Back Into Black; CytRx Slumps After Selling Stock", "Sector Update: Healthcare", "Sector Update: Healthcare", "CytRx gets a vote of confidence", "Healthcare Stocks Falling Hard This Afternoon; CytRx Hits 15-Month High After Prospective Cancer Drug Tests Well", "Sector Update: Healthcare", "Zacks #1 Rank Additions for Thursday - Tale of the Tape", "Zacks #1 Rank Additions for Tuesday - Tale of the Tape", "Biotechs to Watch at the 2012 San Francisco Healthcare Confrences - Analyst Blog", "Stocks Mixed at Session's Half; Gold Tops $1,500 an Ounce, Oil Gains", "Mid-Day Update: Stocks Flat While Commodities Jump Following Long Holiday Weekend", "Sector Update: Healthcare Shares Lower; CytRx Corporation up 14% Pre-Market on Preliminary Phase 2 Results", "Mid-Day Update: Stocks Mixed as GDP Data Weighs; Jobless Claims Rise", "Stocks Mixed at Session's Half on Slowing Q1 Economy; Crude Futures Advance"], "Elapsed Time": ["NOV 12, 2018", "NOV 9, 2018", "JUN 15, 2018", "JUL 28, 2017", "JUL 28, 2017", "JUN 8, 2017", "MAY 30, 2017", "MAY 30, 2017", "NOV 12, 2018", "NOV 9, 2018", "JUN 15, 2018", "AUG 15, 2016", "JUL 29, 2016", "JUL 28, 2016", "JUL 28, 2016", "MAY 18, 2017", "APR 20, 2017", "DEC 30, 2016", "DEC 13, 2016", "AUG 15, 2016", "JUL 29, 2016", "JUL 28, 2016", "JUL 28, 2016", "MAY 18, 2017", "APR 20, 2017", "DEC 30, 2016", "DEC 13, 2016", "AUG 15, 2016", "JUL 29, 2016", "JUL 28, 2016", "JUL 28, 2016", "MAY 18, 2017", "JUL 25, 2016", "JUL 22, 2016", "JUL 21, 2016", "JUL 21, 2016", "JUL 20, 2016", "JUL 20, 2016", "JUL 19, 2016", "JUL 28, 2016", "JUL 18, 2016", "JUL 18, 2016", "JUL 15, 2016", "JUL 15, 2016", "JUL 15, 2016", "JUL 6, 2016", "JUL 6, 2016", "JUL 12, 2016", "JUN 7, 2016", "MAY 24, 2016", "APR 5, 2016", "APR 4, 2016", "APR 4, 2016", "MAR 21, 2016", "MAR 21, 2016", "JUL 5, 2016", "JAN 14, 2016", "NOV 18, 2015", "NOV 17, 2015", "SEP 21, 2015", "SEP 10, 2015", "JUL 21, 2015", "JUL 21, 2015", "FEB 17, 2016", "MAY 4, 2015", "APR 20, 2015", "APR 17, 2015", "JAN 26, 2015", "JAN 21, 2015", "JAN 21, 2015", "JAN 7, 2015", "MAY 22, 2015", "JAN 6, 2015", "DEC 31, 2014", "DEC 4, 2014", "NOV 18, 2014", "OCT 28, 2014", "OCT 13, 2014", "OCT 13, 2014", "JAN 6, 2015", "AUG 21, 2014", "MAY 5, 2014", "MAY 5, 2014", "MAY 1, 2014", "MAY 1, 2014", "MAR 27, 2014", "MAR 13, 2014", "AUG 21, 2014", "DEC 11, 2013", "DEC 11, 2013", "DEC 4, 2013", "OCT 10, 2013", "OCT 9, 2013", "OCT 9, 2013", "SEP 30, 2013", "FEB 7, 2014", "DEC 11, 2013", "DEC 11, 2013", "NOV 29, 2012", "NOV 20, 2012", "JAN 9, 2012", "JUL 5, 2011", "JUL 5, 2011", "SEP 30, 2013", "APR 28, 2011", "APR 28, 2011"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/zacks.com-featured-highlights-include%3A-ralph-lauren-estee-lauder-gms-cytrx-and-t2", "https://www.nasdaq.com/articles/bet-rising-pe-investing-these-5-top-ranked-stocks-2018-11-09", "https://www.nasdaq.com/articles/5-biotech-stocks-under-10-worthy-investors-attention-2018-06-15", "https://www.nasdaq.com/articles/health-care-sector-update-07282017-enta-abbv-cytr-atnm-2017-07-28", "https://www.nasdaq.com/articles/health-care-sector-update-07282017-lmatcytratnm-2017-07-28", "https://www.nasdaq.com/articles/health-care-sector-update-06082017-jnj-pfe-abt-mrk-amgn-cytr-tgtx-qgen-2017-06-08", "https://www.nasdaq.com/articles/wall-street-set-open-red-territory-data-focus-2017-05-30", "https://www.nasdaq.com/articles/us-futures-slip-ahead-economic-data-2017-05-30", "https://www.nasdaq.com/articles/zacks.com-featured-highlights-include%3A-ralph-lauren-estee-lauder-gms-cytrx-and-t2", "https://www.nasdaq.com/articles/bet-rising-pe-investing-these-5-top-ranked-stocks-2018-11-09", "https://www.nasdaq.com/articles/5-biotech-stocks-under-10-worthy-investors-attention-2018-06-15", "https://www.nasdaq.com/articles/cytrx-cytr-is-in-oversold-territory%3A-whats-next-2016-08-15", "https://www.nasdaq.com/articles/what-awaits-acur-other-drug-stocks-this-earnings-season-2016-07-29", "https://www.nasdaq.com/articles/weight-watchers-wtw-q2-earnings%3A-a-surprise-in-store-2016-07-28", "https://www.nasdaq.com/articles/should-you-buy-cytrx-cytr-ahead-of-earnings-2016-07-28", "https://www.nasdaq.com/articles/thursday-sector-leaders-trucking-drugs-2017-05-18", "https://www.nasdaq.com/articles/cytrx-gets-clarity-from-fda-for-aldoxorubicin-nda-shares-up-2017-04-20", "https://www.nasdaq.com/articles/is-the-options-market-predicting-a-spike-in-cytrx-corp-cytr-stock-2016-12-30", "https://www.nasdaq.com/articles/health-care-sector-update-12132016-cytrakaoprto-2016-12-13", "https://www.nasdaq.com/articles/cytrx-cytr-is-in-oversold-territory%3A-whats-next-2016-08-15", "https://www.nasdaq.com/articles/what-awaits-acur-other-drug-stocks-this-earnings-season-2016-07-29", "https://www.nasdaq.com/articles/weight-watchers-wtw-q2-earnings%3A-a-surprise-in-store-2016-07-28", "https://www.nasdaq.com/articles/should-you-buy-cytrx-cytr-ahead-of-earnings-2016-07-28", "https://www.nasdaq.com/articles/thursday-sector-leaders-trucking-drugs-2017-05-18", "https://www.nasdaq.com/articles/cytrx-gets-clarity-from-fda-for-aldoxorubicin-nda-shares-up-2017-04-20", "https://www.nasdaq.com/articles/is-the-options-market-predicting-a-spike-in-cytrx-corp-cytr-stock-2016-12-30", "https://www.nasdaq.com/articles/health-care-sector-update-12132016-cytrakaoprto-2016-12-13", "https://www.nasdaq.com/articles/cytrx-cytr-is-in-oversold-territory%3A-whats-next-2016-08-15", "https://www.nasdaq.com/articles/what-awaits-acur-other-drug-stocks-this-earnings-season-2016-07-29", "https://www.nasdaq.com/articles/weight-watchers-wtw-q2-earnings%3A-a-surprise-in-store-2016-07-28", "https://www.nasdaq.com/articles/should-you-buy-cytrx-cytr-ahead-of-earnings-2016-07-28", "https://www.nasdaq.com/articles/thursday-sector-leaders-trucking-drugs-2017-05-18", "https://www.nasdaq.com/articles/hca-holdings-hca-q2-earnings%3A-uncertainty-in-the-cards-2016-07-25", "https://www.nasdaq.com/articles/varian-var%3A-whats-in-store-for-the-stock-in-q3-earnings-2016-07-22", "https://www.nasdaq.com/articles/can-cryolife-cry-earnings-spring-a-surprise-in-q2-2016-07-21", "https://www.nasdaq.com/articles/c.r.-bard-bcr-well-poised-to-beat-q2-earnings-estimates-2016-07-21", "https://www.nasdaq.com/articles/sarepta-srpt-posts-y-y-wider-q2-loss-eteplirsen-in-focus-2016-07-20", "https://www.nasdaq.com/articles/cytrx-cytr-is-in-oversold-territory%3A-whats-next-2016-07-20", "https://www.nasdaq.com/articles/merck-kgaas-multiple-sclerosis-drug-under-review-in-eu-2016-07-19", "https://www.nasdaq.com/articles/can-ecolab-ecl-spring-an-earnings-surprise-in-q2-2016-07-28", "https://www.nasdaq.com/articles/adeptus-health-adpt-q2-earnings%3A-will-it-beat-estimates-2016-07-18", "https://www.nasdaq.com/articles/athenahealth-athn-q2-earnings%3A-whats-in-the-cards-2016-07-18", "https://www.nasdaq.com/articles/mid-day-market-update-us-stocks-turn-lower-iteris-shares-climb-following-q1-sales-outlook", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-higher-wells-fargo-earnings-meet-estimates-2016-07", "https://www.nasdaq.com/articles/intuitive-surgical-isrg-q2-earnings%3A-whats-in-store-2016-07-15", "https://www.nasdaq.com/articles/bio-techne-tech-set-to-acquire-space-import-export-2016-07-06", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-mnkd-cytr-bmy-2016-07-06", "https://www.nasdaq.com/articles/mid-day-market-update-crude-oil-3-seagate-shares-surge-strong-revenue-guidance-2016-07-12", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity-cytr-biib-z-2016-06-07", "https://www.nasdaq.com/articles/notable-tuesday-option-activity-cytr-gild-ckec-2016-05-24", "https://www.nasdaq.com/articles/cytrx-corp-cytr-in-focus%3A-stock-rises-10.2-in-session-2016-04-05", "https://www.nasdaq.com/articles/mid-day-market-update-ruckus-wireless-surges-acquisition-news-smith-wesson-shares-slide", "https://www.nasdaq.com/articles/monday-sector-leaders-drugs-biotechnology-stocks-2016-04-04", "https://www.nasdaq.com/articles/mid-day-market-update-affymetrix-stock-drops-valeant-shares-spike-higher-2016-03-21", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-edge-lower-sherwin-williams-buy-valspar-113share-2016-03", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-july-5th-2016-07-05", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-january-14th-2016-01-14", "https://www.nasdaq.com/articles/surging-earnings-estimates-signal-good-news-for-cytrx-cytr-2015-11-18", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity-cytr-gnc-trov-2015-11-17", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-higher-lennar-tops-q3-views-2015-09-21", "https://www.nasdaq.com/articles/will-cytrx-cytr-continue-to-surge-higher-2015-09-10", "https://www.nasdaq.com/articles/mid-day-market-update-dow-dips-over-1-harley-davidson-shares-rise-earnings-beat-2015-07-21", "https://www.nasdaq.com/articles/health-care-sector-update-07212015-nvs-cytr-2015-07-21", "https://www.nasdaq.com/articles/will-cytrx-cytr-continue-to-surge-higher-2016-02-17", "https://www.nasdaq.com/articles/why-shares-cytrx-corporation-are-surging-higher-2015-05-04", "https://www.nasdaq.com/articles/cytrx-corporation-cytr-jumps%3A-stock-rises-11.3-tale-of-the-tape-2015-04-20", "https://www.nasdaq.com/articles/why-cytrx-corporation-shares-are-soaring-today-2015-04-17", "https://www.nasdaq.com/articles/cytrx-candidate-encourages-in-soft-tissue-sarcoma-study-analyst-blog-2015-01-26", "https://www.nasdaq.com/articles/advaxis-heavily-promoted-and-misleading-investors-2015-01-21", "https://www.nasdaq.com/articles/cytrx-relieved-as-fda-lifts-partial-hold-on-oncology-drug-analyst-blog-2015-01-21", "https://www.nasdaq.com/articles/cytrx-jumps-on-positive-results-from-brain-cancer-study-analyst-blog-2015-01-07", "https://www.nasdaq.com/articles/should-you-get-rid-of-cytrx-corporation-cytr-now-tale-of-the-tape-2015-05-22", "https://www.nasdaq.com/articles/health-care-sector-update-01062015-cytrtnxpmstx-2015-01-06", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-gain-pacific-ethanol-reports-merger-deal-aventine", "https://www.nasdaq.com/articles/cytrx-falls-on-written-fda-notice-for-aldoxorubicin-study-analyst-blog-2014-12-04", "https://www.nasdaq.com/articles/health-care-sector-update-11182014-nbs-cytr-2014-11-18", "https://www.nasdaq.com/articles/5-red-hot-biotech-stocks-buy-2014-10-28", "https://www.nasdaq.com/articles/sector-update-healthcare-stocks-mixed-cytrx-ahead-6-after-launching-new-drug-discovery-lab", "https://www.nasdaq.com/articles/sector-update-health-care-2014-10-13-0", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-higher-commercial-metals-posts-upbeat-earnings-2015", "https://www.nasdaq.com/articles/three-lessons-galena-scandal-2014-08-21", "https://www.nasdaq.com/articles/healthcare-stocks-little-changed-cytrx-climbs-more-7-after-cancer-drug-extends-progression", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-05-05-0", "https://www.nasdaq.com/articles/mid-day-market-update-weight-watchers-shares-surge-upbeat-results-jds-uniphase-tumbles", "https://www.nasdaq.com/articles/mid-afternoon-market-update-markets-turn-back-meritor-hangs-its-gains-2014-05-01", "https://www.nasdaq.com/articles/behind-scenes-proactive-inovio-and-unilife-2014-03-27", "https://www.nasdaq.com/articles/behind-scenes-dream-team-cytrx-and-galena-2014-03-13", "https://www.nasdaq.com/articles/3-lessons-galena-scandal-2014-08-21", "https://www.nasdaq.com/articles/healthcare-stocks-falling-hard-afternoon-cytrx-hits-15-month-high-after-prospective-cancer", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-12-11-0", "https://www.nasdaq.com/articles/stocks-insiders-sell-google-and-linkedin-2013-12-04", "https://www.nasdaq.com/articles/shares-fall-as-cytrx-prices-stock-offer-analyst-blog-2013-10-10", "https://www.nasdaq.com/articles/healthcare-stocks-inching-back-black-cytrx-slumps-after-selling-stock-2013-10-09", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-10-09-0", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-09-30", "https://www.nasdaq.com/articles/cytrx-gets-vote-confidence-2014-02-07", "https://www.nasdaq.com/articles/healthcare-stocks-falling-hard-afternoon-cytrx-hits-15-month-high-after-prospective-cancer", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-wednesday-tale-of-the-tape-2012-12-12", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-thursday-tale-of-the-tape-2012-11-29", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-tuesday-tale-of-the-tape-2012-11-20", "https://www.nasdaq.com/articles/biotechs-to-watch-at-the-2012-san-francisco-healthcare-confrences-analyst-blog-2012-01-09", "https://www.nasdaq.com/articles/stocks-mixed-sessions-half-gold-tops-1500-ounce-oil-gains-2011-07-05", "https://www.nasdaq.com/articles/mid-day-update-stocks-flat-while-commodities-jump-following-long-holiday-weekend-2011-07", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-lower-cytrx-corporation-14-pre-market-preliminary-phase-2", "https://www.nasdaq.com/articles/mid-day-update-stocks-mixed-gdp-data-weighs-jobless-claims-rise-2011-04-28", "https://www.nasdaq.com/articles/stocks-mixed-sessions-half-slowing-q1-economy-crude-futures-advance-2011-04-28"], "Content": []}